Brightflow
French tech company | Builders Republic
About
Medtech developing an implantable mechanical circulatory support device for end-stage heart failure — a long-term percutaneous pump designed to support a failing right ventricle without open-heart surgery, currently in product development toward first patient implants.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2020
- City
- ORLEANS
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 17 M€ raised since 2020
Funding rounds
- Series A — 2024
Investors
- BNP Paribas Développement
- UI Investissement
- Vives Partners